United States · Series B startup

Who invested in Neuro-ID

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $35MNov 2021
Investors
4
See who backed them
Neuro-IDAnalytics1 / 11Their pitch deckNeuro-ID's pitch deck, 11 slidesEach slide read for what it argues, against the decks that raised at the same stage.

The rounds

  1. Nov 2021
    Series B$35M

    Source recorded

Founders and team

From the SEC filings it signed: 5 on the team.

  • Courtney LaabsExecutive Officeri
  • Jack AltonExecutive Officer, Director, Promoteri
  • Jeff JenkinsExecutive Officer, Directori
  • Jon FetveitExecutive Officeri
  • Joseph ValacichExecutive Officer, Directori

On the board, as filediAl StinsonJack NealLogan Allin

Everyone who backed them

NAPVC firm1round
Fin CapitalPrivate equity1round
TTV CapitalVC firm1round
Canapi VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neuro-ID

Who invested in Neuro-ID?

Neuro-ID's investors include NAP, Fin Capital, TTV Capital and Canapi Ventures.

How much has Neuro-ID raised?

Neuro-ID has raised $35M across 1 round since 2021.

When did Neuro-ID last raise?

Neuro-ID's most recent round was a Series B of $35M in Nov 2021.

What was Neuro-ID's biggest round?

Its most recent round, $35M in Nov 2021, is also its largest on record.

Who backed Neuro-ID first?

Neuro-ID's first round on record, in Nov 2021, was backed by NAP, Fin Capital and TTV Capital and 1 others.

What stage is Neuro-ID at?

Neuro-ID's latest named round is a Series B, in Nov 2021.

Where is Neuro-ID based?

Neuro-ID is based in the United States.

Companies like Neuro-ID

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.